1. Introduction {#sec0005}
===============

Advances in diagnosis and acute treatment lead to increasing number of stroke survivors and consequently increase the demand on rehabilitation centres, families, and other caregivers ([@ref001]; [@ref016]). The neurological deficits resulting from stroke can seriously hamper postural control functions and gait ([@ref017]). Such mobility impairments commonly also affect patients' ability to maintain social engagement ([@ref002]; [@ref037]; [@ref045]). Sedentary lifestyle and social isolation are associated with numerous detrimental health conditions that impact on well-being, and quality of life of stroke survivors. Stroke rehabilitation therefore faces the challenge of finding therapeutic approaches that optimize motor recovery after stroke ([@ref006]; [@ref007]), as reflected by the growing number of studies evaluating promising interventions ([@ref056]).

Functional mobility is increasingly used as an outcome in clinical studies as it may provide a functional measure of the overall health condition (e [@ref023]; [@ref052]). Functional mobility involves person's ability to move independently in a variety of environments in order to participate in the activities of daily living or to perform functional activities such as bed mobility, transfers, ambulation or specific tasks ([@ref012]). Enhanced gait capacity is one of the most important goals of stroke survivors ([@ref027]), and gain in gait speed resulting from the application of therapeutic approaches is a variable of major interest in clinical studies ([@ref020]). Improving mobility is of great importance for achieving independence and the ability to perform daily activities, as well as for re-integration in the community ([@ref032]). It is suggested that improvement in walking speed reflects a genuine improvement in mobility, even if other mostly categorical measures fail to detect it ([@ref034]). Repeated assessment with a simple timed walking test has been validated as a responsive method to detect change in walking performance over time ([@ref013]). Additional gait parameters such as step length, and step rate or cadence have often been analysed in such studies, including stroke survivors ([@ref028]; [@ref034]; Öberg et al., 1993). Significant correlations have been found between walking speed, step length and step frequency in individuals after stroke ([@ref008]; [@ref028]; [@ref054]).

As a growing number of studies challenge the concept of reaching a plateau in stroke recovery ([@ref019]), there is a need to design and evaluate interventions that support continuous stroke recovery ([@ref006]; [@ref007]). Collaborative multidisciplinary research programs that span the complex stroke continuum need to be developed with the ultimate goal of reducing the burden of stroke (Bernhardt et al., 2017a). Growing evidence points to the combination of therapeutic modalities as the key to maximal functional recovery after stroke ([@ref015]; [@ref036]). This treatment strategy is also referred to as multimodal therapy.

We previously reported that emotionally engaging multimodal interventions incorporating horse-riding therapy (H-RT) and rhythm and music-based therapy (R-MT) have potential to influence perceived recovery following stroke ([@ref009]). Both therapeutic modalities incorporate motor, sensory and cognitive stimulation with the goal of promoting recovery after stroke. Both interventions contributed to gains in balance, and H-RT also led to improved functional balance, as measured by the Timed Up and Go test. To enable analyses with respect to the impact of the interventions on gait and functional task performance, additional secondary measures were included in the trial ([@ref009]; [@ref010]). In the present study, we report on the effects of these interventions delivered in the late phase of stroke on participants' gait capacity and functional task performance. Given the explicit motor and sensory inputs of therapeutic riding that are thought to facilitate gait in neurologically disabled individuals, we hypothesised that the H-RT would significantly improve gait capacity.

2. Methods {#sec0010}
==========

2.1. Study design and participants {#sec0015}
----------------------------------

The present study is a part of a three-armed randomized controlled trial, the study protocol, and recruitment procedure of which were previously described ([@ref010]). The eligibility criteria were limited to individuals who suffered from stroke 10 months to 5 years prior to their potential inclusion in the trial. Selection criteria for trial eligibility are presented in [Table 1](#nre-45-nre192905-t001){ref-type="table"}. Participants were consecutively and randomly allocated to one of three parallel groups: H-RT, R-MT or a control group. Participants in the control group received the R-MT intervention a year later. The study was conducted according to the Consolidated Standards of Reporting randomized Trials (CONSORT) ([@ref049]). Evaluation was conducted prior to and directly after the 12-week long intervention, as well as three and six months post-intervention. All participants signed a written informed consent form and were informed that they could withdraw from the study at any time. Ethical approval was granted by the Regional Ethical Review Board in Gothenburg (Ref number: 698-09) and the study is conducted in accordance with relevant ethical guidelines.

###### 

Selection criteria for trial eligibility

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  •Aged 50--75 years
  •Disability grade 2 or 3 on mRS^\*^
  •Chronic impairment after stroke (minimum 10 months to maximum 5 years)
  •Ischaemic or haemorrhagic stroke or subarachnoid haemorrhage with initial presence of hemispheric impact/symptoms
  •Ability to understand written and oral information and instructions in Swedish
  •Live in their own home
  •Able to travel to the place of intervention and evaluation
  •No need for personal assistance in the following activities of daily living while participating in the treatment (going to the toilet, transport/transportation services for disabled, walking)
  •No pronounced fear of horses or allergy constituting a risk for the patients to participate in the therapeutic riding
  •No heart conditions constituting a risk for the individual to participate in the interventions
  •No history of non-controlled epileptic seizures constituting a risk for the patients to participate in the interventions
  •No lack of cognitive and/or verbal ability or visual impairment that would make it difficult for the individual to understand instructions and/or evaluation
  •No total arm paralysis
  •No injury, disease or addiction that would render the individual unsuitable for the trial
  •Bodyweight≤97 kg (to optimise safe horseback riding)
  •No more than half-time employment
  •No participation in RMT or HRT \< 10 months prior to inclusion
  •No additional stroke within the past year (TIA is however accepted)
  •Accepting allocation to either of the three groups which might mean accepting staying without any of the treatment procedures for one year
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^\*^Modified Rankin Scale: An ordinal disability rating scale ranging from zero to 6 (0 = no symptoms). mRS grade 1: No significant disability despite symptoms; able to carry out all usual duties and activities; mRS grade 2 = *Slight disability*: unable to carry out all previous activities but able to look after own affairs without assistance; mRS grade 3 = *Moderate disability*: requiring some help, but able to walk without assistance; mRS grade 4: *Moderately severe disability*: unable to walk without assistance and unable to attend to own bodily needs without assistance; mRS grade 5: *Severe disability*: bedridden, incontinent and requiring constant nursing care and attention; mRS grade 6: Dead.

2.2. Randomisation and blinding {#sec0020}
-------------------------------

As gender and brain laterality might influence outcomes in clinical studies,([@ref033]) the randomisation was stratified with respect to gender and hemispheric location of the stroke. A statistician performed computer-generated randomisation using random permuted blocks for each of the 2×2 strata. Block size was known only by the statistician who performed the randomisation. Another independent person sequentially numbered opaque envelopes, each of which contained the name of the intervention group that had been determined by the randomisation. The participants were consecutively recruited to the randomisation list by the project leader. The envelopes were opened in sequential order as each participant entered the trial. Randomisation codes were not accessed until all measurements were completed. Assessors were blinded to treatment allocation. Due to the nature of the therapy programs, blinding of participants and treating therapists was not feasible. Data analysts were not blinded. To keep assessors blinded, participants and intervention therapists were instructed not to reveal treatment allocation or participants' study experiences to the assessors.

2.3. Interventions {#sec0025}
------------------

During the 12 weeks of intervention, participants attended two weekly sessions of the R-MT or H-RT. Both interventions have the common feature that they provide an enriched environment designed to stimulate motor, cognitive, sensory, and social functions. They differ, however, in terms of dosage, execution, activities, and targeted outcomes. A detailed description of the interventions as well as the specification of how the therapeutic modalities are expected to affect targeted outcomes are presented in [Supplementary file 1](#S1){ref-type="supplementary-material"}. Participants in the delayed R-MT group (controls) were told not to start any new therapies during the duration of the study, but were allowed to continue with their regular activities and usual care such as outpatient physiotherapy, occupational therapy, or speech therapy.

2.4. Statistical analyses {#sec0030}
-------------------------

According the sample size calculation described previously ([@ref010]), at least 41 patients were required in each of the three groups for the results to satisfy the power criteria of 80%. Analyses were done according to intention-to-treat (ITT). In addition, a per-protocol analysis was performed. The outcome is analyzed in terms of change from baseline to each measurement point. Baseline and demographic characteristics are summarized using descriptive statistics. QQ-plots and histograms as well as skewness and kurtosis were used to assess whether the outcome variables approximated a normal distribution. Analyses of covariance (ANCOVA) with gain in each outcome measure as a dependent variable, initial score of each outcome measure as a covariate, and intervention group as factor, were done using SPSS v.22.0 (IBM Corp., Armonk, NY, USA). The results were considered significant if *P* was less than .05.

3. Measures {#sec0035}
===========

3.1. Assessment of gait capacity {#sec0040}
--------------------------------

To measure gait speed the timed 10 meter walk test (10 mWT) was used ([@ref022]) The test is performed on a 10-meter distance marked by tape on the floor. In the first round the subject was asked to walk at a self-selected walking speed. In the second round, they were instructed to walk as fast as they could. Walking aids were allowed. Walking time was measured in seconds. The number of steps was calculated and conversed into step length. In order to determine whether potential gains in terms of gait reached the level established as a meaningful change ([@ref040]), as well as the suggested cut-off point for community ambulation ([@ref055]), gait speed was also expressed in meters per second, by dividing distance (in metres) by time (in seconds). The 10 mWT has been widely used for locomotion studies involving various patient groups ([@ref038]). The test is considered to have high reliability and low variability as an interrater and test-retest ([@ref041]; [@ref052]).

After the first intervention group had been enrolled and randomized, the six-minute walk test (6 MWT) was added to the outcome measures. The 6 MWT is a sub-maximal exercise test used to assess walking endurance ([@ref014]; [@ref051]).

3.2. Observer-assessed functional mobility performance {#sec0045}
------------------------------------------------------

As a means of assessing everyday motor function in patients with stroke the Modified Motor Assessment Scale according to Uppsala University Hospital (M-MAS UAS) was used ([@ref003]). The M-MAS UAS is a modification of the original MAS described by Carr et al. ([@ref011]). The instrument is based on the Motor Assessment Scale (MAS) which is a performance-based scale based on a task-oriented approach that assesses performance of functional tasks rather than isolated patterns of movement ([@ref011]). The maximum score of 55 indicates good motor function. It has been modified and developed twice since 1991, as well as tested for reliability and validity in different studies ([@ref044]). In this study, the M-MAS UAS version 1999 was be used ([@ref004]). The M-MAS UAS measures motor control in eight levels: A: horizontal displacement, B: back lying to sitting movement, C: sitting down, D: sitting to standing, E: walking, F: arm functionality, G: hand movements and H: fine motor skills. The total M-MAS score was used to reflect a more global perspective of functional mobility capacity (e [@ref023]; [@ref052]).

4. Results {#sec0050}
==========

All 123 individuals (mean age of 63 years, age range 49--74) who were enrolled in the RCT were included in these analyses. The average number of days elapsed from the stroke insult was 1056 days (range: 318--3624). Exclusion and drop-out throughout the RCT was reported previously ([@ref009]). Mean attendance rate at the H-RT and R-MT was 83% and 88% respectively, equivalent to at least 20 treatment sessions (SD 5.0) for the H-RT group and at least 21 treatment sessions (SD 4.0) for the R-MT group. Baseline demographic and clinical characteristics of trial participants are presented in [Table 2](#nre-45-nre192905-t002){ref-type="table"}. Demographic data were well balanced, with no differences between groups. Clinical characteristics indicated a trend towards greater mobility impairment in the H-RT group with respect to the timed 10 mWT (ANOVA; *p* = 0.08). No differences were observed between participants who completed the intervention and those who did not (dropouts) with regard to baseline demographic and clinical characteristics. One participant in the R-MT died during the intervention period and was excluded from the analyses.

###### 

Demographic characteristics of study participants

                                       R-MT (*n* = 41)        H-RT (*n* = 41)     Control (*n* = 41)
  --------------------------------- ---------------------- --------------------- ---------------------
  Variable                                                                       
  Sex: Women/Men (%)                 18 (43.9)/ 23 (56.1)   17 (41.5)/24 (58.5)   19 (46.3)/22 (53.7)
  Age in years                            62.7 (6.7)            62.6 (6.5)            63.7 (6.7)
  Years of schooling                      14.2 (4.1)            12.5 (4.2)            13.5 (4.3)
  Time since stroke onset in days       969.8 (422.9)         1101.9 (576.1)        1096.3 (439.0)
  Site of the stroke lesion                                                      
    Right (%)/Left (%)               20 (48.8)/ 21 (51.2)   20 (48.8)/21 (51.2)   18 (43.9)/22 (53.7)
  Stroke type                                                                    
    Haemorrhage (%)/Infarct (%)      9 (22.0)/ 32 (78.0)    14 (34.1)/27 (65.9)   13 (31.7)/28 (68.3)
  Modified Rankin Scale                                                          
    Grade 2 (%)/Grade 3 (%)          24 (58.5)/ 17 (51.5)   23 (56.1)/18 (43.9)   25 (61.0)/16 (39.0)
  NIHSS                                   3.0 (2.9)              2.7 (3.1)             2.8 (3.6)
  10 mWT Time (sec)                                                              
    *Self-selected speed*                10.03 (3.02)          15.05 (14.90)         13.37 (8.55)
    *Fast speed*                         7.26 (2.93)            9.71 (7.71)           9.84 (7.10)
  6 MWT (meters)                       437.69 (107.03)        361.29 (138.02)       374.89 (166.77)
  M-MAS-UAS                              51.39 (5.92)          49.63 (6.83)          50.80 (5.80)

Data are number (%) or mean (SD). H-RT = Horse-riding therapy; R-MT = Rhythm and music-based therapy; NIHSS = The National Institutes Health Stroke Scales, 10 mWT: 10-meter walk test; 6 MWT: 6-minute walk test, M-MAS UAS = Modified Motor Assessment Scale (Uppsala University Hospital).

Changes in gait and mobility parameters for the three study groups at post-test and at the 6 months follow-up are summarized in [Table 3](#nre-45-nre192905-t003){ref-type="table"}. Immediately after intervention, the mean time to complete the 10-meter walk in self-selected speed for the H-RT and R-MT participants was reduced by 2.22 (±4.24) and 0.53 (±1.41) seconds, respectively, as compared to an increase of 0.37 (±4.13) in the control group ([Fig. 1](#nre-45-nre192905-g001){ref-type="fig"}). The corresponding improvement for fast speed was 1.19 (±3.14) seconds in the H-RT group, while there was no change in RM-T group, and the control group performed worse compared to baseline ([Table 3](#nre-45-nre192905-t003){ref-type="table"}). Analyses with ANCOVA revealed that the improvements in the timed 10-meter walk at both self-selected and fast walking speed were significant (*p* = 0.006 and *p* = 0.011, respectively). Further pairwise comparisons showed that these differences were ascribed to the H-RT group (*p* = 0.001 and *p* = 0.003, respectively).

![The change in the 10-meter walk test in self-selected speed from baseline to each evaluation point presented as mean (95% confidence interval).](nre-45-nre192905-g001){#nre-45-nre192905-g001}

###### 

Changes in functional mobility performance for the study groups post intervention and at the 6-month follow-up according to ITT

                                Within-group changes from baseline to follow-up   Between-group differences                                       
  ---------------------------- ------------------------------------------------- --------------------------- ---------------------------- ------- -------
                                                R-MT (*n* = 40)                        H-RT (*n* = 41)            Control (*n* = 41)        *P*     *P*
                                   Change from baseline to post-intervention                                                                      
  10 mWT Time (sec)                                                                                                                               
    *Self-selected speed*                  --0.54 (--0.98 to --0.09)              --2.22 (--3.55 to --0.88)     0.37 (--0.94 to 1.68)      5.68    0.006
    *Fast speed*                            --0.14 (--0.44 to 0.16)               --1.19 (--2.18 to --0.18)     0.88 (--0.40 to 2.16)      4.70    0.011
  10 mWT Number of steps (n)                                                                                                                      
    *Self-selected speed*                   --0.41 (--0.90 to 0.07)               --2.17 (--3.30 to --1.04)     0.41 (--0.72 to 1.55)      7.05    0.002
    *Fast speed*                            --0.32 (--0.74 to 0.10)               --1.40 (--2.36 to --0.44)     0.44 (--0.75 to 1.63)      4.11    0.020
  10 mWT Step length (meter)                                                                                                                      
    *Self-selected speed*                   0.021 (0.003 to 0.039)                 0.038 (0.022 to 0.054)      0.010 (--0.006 to 0.026)    2.912   0.058
    *Fast speed*                           0.025 (--0.001 to 0.052)                0.039 (0.014 to 0.065)      0.010 (--0.005 to 0.025)    1.843   0.163
  6 MWT (meters)                          15.69 (--1.69 to 33.08)^\*^             27.06 (15.39 to 38.72)^†^   8.60 (--3.28 to 20.48)^†^    1.82    0.177
  M-MAS-UAS                                   0.62 (0.27 to 1.01)                    1.13 (0.74 to 1.52)        0.18 (--0.20 to 0.57)      5.74    0.004
                                   Change from baseline to 6-month follow-up                                                                      
  10 mWT Time (sec)                                                                                                                               
    *Self-selected speed*                  --0.75 (--1.36 to --0.14)              --2.12 (--3.45 to --0.78)     0.63 (--0.97 to 2.22)      4.91    0.009
    *Fast speed*                            --0.04 (--0.48 to 0.41)               --0.90 (--1.69 to --0.10)     1.28 (--0.58 to 3.13)      3.35    0.040
  10 mWT Number of steps (n)                                                                                                                      
    *Self-selected speed*                  --0.76 (--1.46 to --0.05)               --2.93 (--5.94 to 0.09)      1.17 (--0.38 to 2.72)      4.31    0.016
    *Fast speed*                            --0.18 (--0.84 to 0.49)                --0.83 (--1.71 to 0.06)      1.07 (--0.41 to 2.56)      3.33    0.039
  10 mWT Step length (meter)                                                                                                                      
    *Self-selected speed*                   0.030 (0.007 to 0.053)                  0.037(0.020 to 0.055)      0.000 (--0.021 to 0.035)    3.594   0.031
    *Fast speed*                           0.005 (--0.022 to 0.031)                0.031 (0.007 to 0.054)     --0.005 (--0.026 to 0.017)   2.308   0.104
  6 MWT (meters)                          7.81 (--14.91 to 30.52)^\*^             25.17 (12.88 to 37.46)^†^   4.77 (--13.60 to 23.14)^†^   1.47    0.243
  M-MAS-UAS                                   0.68 (0.20 to 1.15)                    0.61 (0.06 to 1.16)        0.27 (--0.06 to 0.59)      1.264   0.286

Data are mean (95% CI). Data available for: ^\*^36; ^†^35; participants. 10 mWT: 10-meter walk test; 6 MWT: 6-minute walk test, M-MAS UAS = Modified Motor Assessment Scale (Uppsala University Hospital).

After the intervention, the groups differed also with respect to the number of steps taken during self-selected and fast 10-meter walk (*p* = 0.002 and *p* = 0.020, respectively). Further analysis showed that the difference post-intervention was ascribed to the H-RT group (*p* \< 0.001 and *p* = 0.005, respectively). When data derived from the 10 mWT (self-selected and fast speed) was converted into step length, we did not find any between-group differences at post-intervention. The increase in distance covered in the 6MWT did not differ between the groups (*p* = 0.177). Improvements were also found in the performance of functional tasks as measured by M-MAS UAS (*p* = 0.001). Further pairwise comparisons showed that these differences were ascribed to the H-RT group (*p* = 0.001).

At 6 months, there was a significant between-group difference with respect to self-selected gait speed and step length during the timed 10-meter walk (*p* = 0.009 and 0.031). Further pairwise comparisons showed that the increase in self-selected gait speed and step length were ascribed to both the R-MT (*p* = 0.035 and 0.047), and H-RT group (*p* = 0.031 and 0.013). The between-group difference at 6 months for the timed 10-meter walk at fast walking speed remained significant in favor of the H-RT group (*p* = 0.011). At the 6 month follow-up, the differences between groups with respect to the number of steps taken during self-selected and fast 10-meter walk were sustained (*p* = 0.001 and *p* = 0.042, respectively). Further analysis ascertained that the difference in the number of steps taken at self-selected speed was ascribed to both the H-RT and R-MT group (*p* \< 0.001 and *p* = 0.015, respectively), whereas for fast speed, the difference was in favor of only the H-RT group (*p* = 0.003). The immediate gains in functional mobility performance among H-RT participants as measured by M-MAS UAS, were not sustained at 6 months. The results of the additional per-protocol analysis were consistent with those of the analysis according to ITT.

5. Discussion {#sec0055}
=============

This study shows that a heterogeneous population of late-phase stroke survivors can achieve functional gains by engaging in multimodal interventions. Participants in the H-RT group demonstrated immediate and sustained (6-month follow-up) improvement in short distance walking capacity, at both self-selected and fast speed. They walked the 10-meter distance faster and with fewer steps. In the R-MT group, an improvement was observed only at the 6-month follow-up, when they performed better at self-selected speed.

Walking speed was tested by timing a 10-meter walk at self-selected but also fast speed, since that may be important in community-based activities such as crossing a street ([@ref034]). The immediate improvement in the timed 10-meter walk at self-selected gait speed for the H-RT group was 0.08 (±0.12) m/s, and thus reached the level of 0.06 m/s, established as a small but meaningful change ([@ref040]). At 6 months post-intervention, the gait speed gains for both the H-RT and R-MT group (0.09 m/s) also represent a small but meaningful change. These results are comparable with the increase in gait speed (comfortable speed in 7 out of 9 included studies) by 0.07 m/s, described in a systematic review of gait training after stroke ([@ref039]). Notably, cardiovascular improvement occurring in the later phase after stroke is conceivably limited due to the high energy demands of hemiplegic gait and the poor physical condition of stroke survivors ([@ref031]; [@ref057]). The H-RT but not R-MT led to improvements in functional motor performance as measured by M-MAS UAS. The clinical relevance of this result is not clear, as the minimum detectable change and the minimal clinically important difference of the M-MAS UAS are yet to be determined ([@ref025]).

H-RT and R-MT are specifically adapted to neurologically disabled individuals, including stroke survivors ([@ref009]; [@ref035]). In H-RT, the three-dimensional movements of the horse stimulate several different muscle groups ([@ref046]), as well as the motor system ([@ref026]). H-RT stimulates a similar rhythmical and repetitive pelvic movement of the rider as normal gait, which can provide important motor and sensory stimulus in persons with reduced mobility ([@ref046]). R-MT on the other hand, is based on exercises that challenge cognitive function and sensorimotor control, with the aim to improve coordination, mobility and cognition in patients with neurological deficits through the use of rhythm and music ([@ref042]). The explicit motor component of H-RT may have resulted in the immediate and more pronounced effects of this intervention with regard to gait and functional mobility ([@ref050]). ANCOVA theoretically yields unbiased estimates of intervention effect ([@ref024]). However, in light of the trend towards between-group differences in baseline functional impairment, we cannot exclude that the smaller effect of R-MT observed in our study was at least partially due to a lower degree of functional impairment in the R-MT group.

We previously reported that the proportion of participants who felt they had achieved a meaningful recovery post-intervention was higher in the H-RT (56%) compared with the R-MT group (38%) ([@ref009]). These primary outcome findings are well in line with the results of the present study. At 6 months, the proportion of participants who felt they had achieved a meaningful recovery was 56 and 43%, for the H-RT and R-MT group, respectively indicating a continued improvement among R-MT participants ([@ref009]). The post-intervention assessment further showed improvements in static/dynamic and functional balance ability, as measured by Berg Balance Scale (BBS) and Timed Up and Go (TUG) test, respectively in the H-RT group ([@ref009]). In the R-MT group, improvement was detected by Bäckstrand Dahlberg and Liljenäs (BDL) balance scale but not BBS ([@ref009]). The BDL scale is more demanding with regard to balance complexity, and is therefore more sensitive in detecting small improvement compared to BBS ([@ref048]).

The findings from both studies indicate that the motor component is more pronounced in HR-T, than R-MT. The H-RT may more specifically target the common coordination deficits after stroke, including altered temporal and spatial coordination between the head, trunk and pelvis([@ref029]), that were suggested to affect gait execution ([@ref017]). Moreover, H-RT is shown to reduce spasticity ([@ref047]), which may facilitate various gait parameters ([@ref030]). The H-RT participants in the present study were able to walk faster with fewer steps after the intervention, with a significant increase in step length at 6 months. This may have been achieved by improved balance or lower limb coordination reported previously ([@ref009]).

The long-term positive effects of R-MT on balance, gait and working memory, as found in this and our previous study^9^ are also of importance as the improvement in these variables at the 6-month follow-up may reflect continued recovery after end of intervention. As interventions targeting lower limb coordination appear to improve walking for individuals with stroke ([@ref029]), the high demands of R-MT on coordination may have contributed to the improvement in gait capacity through the same mechanism.

In view of participants' own experiences of these multimodal interventions, both encounter enriching experiences that may have positive impacts on their emotional and physical state ([@ref042]; [@ref043]). The in-depth interviews indicate that the social interplay and the practical activities were considered as equally important among the participants themselves ([@ref043]). As previously mentioned, certain limitations of our study must be considered when interpreting the results ([@ref009]). Due to the eligibility criteria in the RCT, our study population was limited to individuals with moderate impairment after stroke (mRS grade 2 and 3). The study did not enrol individuals dependent on external help (mRS grade 4), as their possibility to actively participate in the interventions is limited and they often have other needs for support and rehabilitation. Whereas these individuals could potentially benefit from multimodal interventions like those used in our study, the, inclusion of individuals with minor residual disabilities would conceivably not be justifiable in terms of cost-effectiveness. Future research should aim to extend our findings to these groups and determine the cost-effectiveness of multimodal post-stroke interventions. The present study has strengths such as the concealed design, stratified randomization, valid and reliable outcome measure, both an ITT and PP analysis and a low drop-out rate ([@ref009]). Given that improvements occurring in the later phase after stroke are considered to be barely noticeable ([@ref021]), it is not surprising that the present study did not find any large effects of the interventions. Our findings, however, provide further support to the notion that potential for further recovery in functional mobility exists in late phase after stroke.

In conclusion, our results show that H-RT could be effective in producing improvement in gait and functional mobility in late-phase stroke survivors, whereas the effectiveness of R-MT is less clear. Further research needs to determine whether the benefits of H-RT are cost-effective and whether these conclusions can be extended to other populations of stroke survivors.
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